<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="49005">Deferasirox</z:chebi> is a new oral iron <z:chebi fb="0" ids="38161">chelator</z:chebi> used to treat transfusional <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a case of a 79-year-old man with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) who developed <z:hpo ids='HP_0100633'>esophagitis</z:hpo> induced by <z:chebi fb="0" ids="49005">deferasirox</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>He repeatedly received multiple red blood cell transfusions after a diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Two years after starting red blood cell transfusions, he was diagnosed with <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e>, and was then started on <z:chebi fb="0" ids="49005">deferasirox</z:chebi> at 1 g/day with about 400 ml of water </plain></SENT>
<SENT sid="4" pm="."><plain>He was admitted to our institution because he was unable to swallow his own saliva 1 month after starting <z:chebi fb="0" ids="49005">deferasirox</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Esophagogastroendoscopy revealed white-coated mucosa covering the entire esophagus </plain></SENT>
<SENT sid="6" pm="."><plain>A component analysis of biopsy specimens using high-performance liquid chromatography identified <z:chebi fb="0" ids="49005">deferasirox</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Symptoms resolved within about 2 weeks after discontinuing <z:chebi fb="0" ids="49005">deferasirox</z:chebi>, and repeated endoscopy showed marked improvement of <z:hpo ids='HP_0100633'>esophagitis</z:hpo> after 1 month </plain></SENT>
<SENT sid="8" pm="."><plain>Re-administration of <z:chebi fb="0" ids="49005">deferasirox</z:chebi> was not attempted </plain></SENT>
<SENT sid="9" pm="."><plain>Unfortunately, the patient died due to <z:hpo ids='HP_0002090'>pneumonia</z:hpo> 6 months after administration of <z:chebi fb="0" ids="49005">deferasirox</z:chebi> was started </plain></SENT>
<SENT sid="10" pm="."><plain>This is the first report of drug-induced <z:hpo ids='HP_0100633'>esophagitis</z:hpo> associated with <z:chebi fb="0" ids="49005">deferasirox</z:chebi> </plain></SENT>
</text></document>